The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

Recent advances in immunotherapy and combination therapies are revolutionizing the treatment landscape for both metastatic ...

Here the authors report the design and characterization of a biodegradable urease-powered nanomotor containing STING agonist, promoting anti-tumor immune responses in bladder cancer models.

Detailed price information for Iovance Biotherapeutics Inc (IOVA-Q) from The Globe and Mail including charting and trades.

Bladder training is a behavioral treatment that may be effective in eliminating bedwetting (or enuresis) among children. Bladder training seeks to increase the capacity of the bladder and the strength ...

Source: Getty Images Perioperative durvalumab has “the potential to transform the standard of care” for patients with muscle-invasive bladder cancer, according to Thomas Powles ... to receive ...

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to ...

Some people feel bladder issues are an embarrassing topic or they simply don’t realize their symptoms could signal a larger health issue. Bladder cancer is the fourth most common cancer in men and the ...